Metabolomic insights: LC–MS profiling of human placental tissue from SSRI-treated pregnancies
Authors:
Open Access
- 12 January 2026
- journal article
- research article
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Abstract
Antenatal depression, a common pregnancy complication, poses significant risks if untreated. Consequently, pregnant mothers are prescribed selective serotoKeywords
Funding Information
- Horizon 2020 Framework Programme (825762)
This publication has 55 references indexed in Scilit:
- Longitudinal metabolic profiling of women using selective serotonin reuptake inhibitors during pregnancyMetabolomics, 2025
- Analysis of early-pregnancy metabolome in early- and late-onset gestational diabetes reveals distinct associations with maternal overweightDiabetologia, 2024
- A non-targeted LC–MS metabolic profiling of pregnancy: longitudinal evidence from healthy and pre-eclamptic pregnanciesMetabolomics, 2021
- Biomarkers of placental redox imbalance in pregnancies with preeclampsia and consequent perinatal outcomesArchives of Biochemistry and Biophysics, 2020
- Glutathione in Brain: Overview of Its Conformations, Functions, Biochemical Characteristics, Quantitation and Potential Therapeutic Role in Brain DisordersNeurochemical Research, 2020
- Redox metabolism modulation as a mechanism in SSRI toxicity and pharmacological effectsArchives of Toxicology, 2020
- Nutrimetabolomics: An Integrative Action for Metabolomic Analyses in Human Nutritional StudiesMolecular Nutrition & Food Research, 2018
- Regulation of neuronal development and function by ROSFEBS Letters, 2018
- Proposed minimum reporting standards for chemical analysisMetabolomics, 2007
- Oxidative stress in the placentaHistochemistry and Cell Biology, 2004